This bibliometric analysis explores Sargassum as a potential diabetes treatment, indicating gaps and suggesting collaboration in herbal medicine research.
The prevalence of diabetes mellitus (DM) has increased significantly, with Sargassum emerging as a potential therapeutic agent. Despite the abundant literature on Sargassum antidiabetic properties, bibliometric analyses have yet to be conducted. This study aimed to bridge this gap by conducting a bibliometric analysis of existing articles on preclinical trials of Sargassum for managing DM. Leveraging Scopus, we compiled a bibliographic database encompassing primary research articles in this domain. Sixty-four publications spanning from 2008 to 2023 were meticulously selected for analysis. These articles underwent bibliometric scrutiny using the RStudio® and VOS viewer applications. China emerged as the most influential country, with the South China University of Technology leading among institutions and the International Journal of Biological Macromolecules serving as the primary source. Notably, Chao Li was identified as the most impactful author in this domain. The study covered phytochemistry and pharmacology, which were the predominant and diverse fields. Our findings encourage research collaboration and illuminate critical research gaps essential for advancing the applications of herbal medicine.
No takes yet. Share an insight, caveat, or question.
Samudra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: